1. Home
  2. NAMS vs WGO Comparison

NAMS vs WGO Comparison

Compare NAMS & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • WGO
  • Stock Information
  • Founded
  • NAMS 2019
  • WGO 1958
  • Country
  • NAMS Netherlands
  • WGO United States
  • Employees
  • NAMS N/A
  • WGO N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • NAMS Health Care
  • WGO Industrials
  • Exchange
  • NAMS Nasdaq
  • WGO Nasdaq
  • Market Cap
  • NAMS 1.7B
  • WGO 1.6B
  • IPO Year
  • NAMS N/A
  • WGO N/A
  • Fundamental
  • Price
  • NAMS $25.50
  • WGO $50.14
  • Analyst Decision
  • NAMS Strong Buy
  • WGO Strong Buy
  • Analyst Count
  • NAMS 6
  • WGO 8
  • Target Price
  • NAMS $36.20
  • WGO $67.14
  • AVG Volume (30 Days)
  • NAMS 1.4M
  • WGO 690.2K
  • Earning Date
  • NAMS 02-06-2025
  • WGO 12-20-2024
  • Dividend Yield
  • NAMS N/A
  • WGO 2.72%
  • EPS Growth
  • NAMS N/A
  • WGO N/A
  • EPS
  • NAMS N/A
  • WGO N/A
  • Revenue
  • NAMS $33,594,000.00
  • WGO $2,836,100,000.00
  • Revenue This Year
  • NAMS $129.49
  • WGO $1.73
  • Revenue Next Year
  • NAMS N/A
  • WGO $8.73
  • P/E Ratio
  • NAMS N/A
  • WGO N/A
  • Revenue Growth
  • NAMS 78.77
  • WGO N/A
  • 52 Week Low
  • NAMS $10.50
  • WGO $49.68
  • 52 Week High
  • NAMS $27.29
  • WGO $74.61
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 62.30
  • WGO 28.07
  • Support Level
  • NAMS $24.40
  • WGO $54.16
  • Resistance Level
  • NAMS $26.95
  • WGO $58.68
  • Average True Range (ATR)
  • NAMS 1.66
  • WGO 1.88
  • MACD
  • NAMS 0.41
  • WGO -0.68
  • Stochastic Oscillator
  • NAMS 81.51
  • WGO 12.53

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: